En esta página
01NTRA precio
02Instantánea
03Gráfico
05Acerca de
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
23Noticias
26Mis Métricas
NTRA Natera, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 6, 2026 10-K/10-Q Ago 7, 2026
$400,65
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$167,33mínimo 52 semanas
$437,41máximo 52 semanas
Capitalización Bursátil (MRQ)
$57.54B
P/E (TTM)
-296.8
BPA (TTM)
$-1.35
Ingresos (TTM)
$2.71B
tus insignias
Rango 52S
$167–$437
Calificación del Analista
BUY
Precio Objetivo
$361
P/E
-296.8
ROE
-12.5%
Margen de Beneficio Neto
-7.1%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
NTRA Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$400.65
Capitalización Bursátil (MRQ)
$57.54B
P/E (TTM)
-296.8
BPA (TTM)
$-1.35
Ingresos (TTM)
$2.71B
ROE (TTM)
-12.5%
Deuda/Capital (MRQ)
0.0
Rango 52S
$167–$437
NTRA Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Acerca de Natera, Inc. - Common Stock Descripción general de la empresa de Wikipedia
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California and Austin, Texas.
History
Natera (previously Gene Security Network) was founded by Matthew Rabinowitz and Jonathan Sheena in 2004. Natera launched its first product, the Spectrum preimplantation genetic test, in 2009.
In 2010, the company introduced the Anora miscarriage (POC) test. Natera's advanced carrier screening test, Horizon, launched in 2012. The following year, 2013, Natera launched the Panorama non-invasive prenatal test (NIPT).
In July 2015, Natera conducted an initial public offering of common stock at a price of $18.00 per share. The shares trade on the Nasdaq Global Select Market under the symbol "NTRA."
In 2017, Natera launched the Vistara single-gene NIPT. That same year, Natera introduced the Signatera molecular residual disease (MRD) test for research use only. The Signatera CLIA test was introduced for clinical use in 2019.
In 2018 Natera paid a $11 million fine to the department over allegations of improper billing and sales of Panorama to federal Healthcare services between the years of 2013 to 2016.
Natera launched the Prospera dd-cfDNA transplant assessment test in 2019, and the Renasight kidney gene panel and the Empower hereditary cancer test in 2020.
As of May 2021, Natera has performed over 3 million cell-free DNA tests. Natera's technology has also been written about in over 200 peer-reviewed journals and publications, including Nature, Science Magazine, and the Journal of Clinical Oncology.
Products and services
Women's health
The Panorama NIPT is the only single-nucleotide polymorphism (SNP)-based NIPT. The test analyzes fetal DNA found in the mother's blood to reveal a baby's risk for genetic disorders such as Down syndrome (trisomy 21) and Edwards syndrome (trisomy 18) as early as nine weeks. Panorama also tests for unique microdeletions and is the only test that can detect zygosity and fetal sex in twins.
Natera also offers Horizon, a carrier-screening test that uses next-generation sequencing to provide carrier status for up to 274 genetic conditions. Additionally, Natera offers the Anora products of conception (POC) miscarriage test, the Spectrum preimplantation genetic screening and diagnosis test, and the Vistara single-gene prenatal screening test. In 2020, Natera launched Empower, a hereditary cancer test that screens for up to 53 genes associated with increased risk for common hereditary cancers.
Oncology
Signatera is the first circulating tumor DNA (ctDNA) assay built for molecular residual disease (MRD) detection and cancer recurrence monitoring. In 2020, Signatera received the CE Mark, as well as final Medicare coverage in stage II-III colorectal cancer and draft coverage in immunotherapy response monitoring. Signatera has been clinically validated to detect colorectal cancer recurrence up to 16.5 months in advance of radiologic imaging and early-stage breast cancer up to two years earlier than imaging.
Organ health
The Prospera test is the first assay with high sensitivity to both T-cell-mediated and antibody-mediated rejection. In December 2019, the test received final Medicare coverage. In 2020, Natera launched Renasight, a test to determine if there is a genetic cause for an individual's kidney disease and if there may be other at-risk relatives.
Constellation
Natera offers a cloud-based bioinformatics platform called Constellation, allowing laboratories to access and use Natera's technology in their own facilities. Constellation is currently only available outside of the United States.
Fuente: Wikipedia (Inglés), CC BY-SA 4.0 · Ver en Wikipedia ↗
sectorHealthcare
industriaBiotechnology
empleados6 135
paísUS
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$2.31B2016-12-31 → 2025-12-31
BPA$-1.522016-12-31 → 2025-12-31
Flujo de caja libre$109M2016-12-31 → 2025-12-31
Margen neto-7.1%2016-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | NTRA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | -296.8promedio 5A ≈-59.2 | ≈-59.2 | · | · | |
| P/S (TTM) | 21.3promedio 5A ≈10.6 | ≈10.6 | 7.3 | Sobrevalorado | |
| P/C (MRQ) | 31.6promedio 5A ≈13.2 | ≈13.2 | 6.2 | Sobrevalorado | |
| Precio / FCF (TTM) | 683.4promedio 5A ≈107.5 | ≈107.5 | · | · | |
| Precio / Flujo de Caja (TTM) | 252.1promedio 5A ≈47.2 | ≈47.2 | 18.3 | Sobrevalorado | |
| Precio / Valor Contable Tangible (MRQ) | 39.4promedio 5A ≈14.8 | ≈14.8 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | NTRA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Operativo (TTM) | -10.7%promedio 5A ≈-41.7% | ≈-41.7% | 24.0% | Débil | |
| Margen EBITDA (TTM) | -8.8%promedio 5A ≈-39.8% | ≈-39.8% | 17.9% | Débil | |
| Margen antes de impuestos (TTM) | -9.3%promedio 5A ≈-41.0% | ≈-41.0% | 13.8% | Débil | |
| Margen de Beneficio Neto (TTM) | -7.1%promedio 5A ≈-40.5% | ≈-40.5% | 12.7% | Débil | |
| ROA (TTM) | -8.7%promedio 5A ≈-27.7% | ≈-27.7% | 11.5% | Débil | |
| ROE (TTM) | -12.5%promedio 5A ≈-51.6% | ≈-51.6% | 18.7% | Débil | |
| ROIC | -13.4%promedio 5A ≈-43.9% | ≈-43.9% | 17.3% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | NTRA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Deuda / Patrimonio (MRQ) | 0.0promedio 5A ≈0.1 | ≈0.1 | 0.1 | Baja deuda | |
| Ratio corriente (MRQ) | 3.0promedio 5A ≈4.1 | ≈4.1 | 3.2 | Baja liquidez | |
| Quick Ratio (Ratio Rápido) | 0.7promedio 5A ≈2.3 | ≈2.3 | 2.5 | Baja liquidez | |
| Interest Coverage (Cobertura de Intereses) | -76.2promedio 5A ≈-49.3 | ≈-49.3 | 8.1 | Baja liquidez |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | NTRA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | 35.9%promedio 5A ≈43.1% | ≈43.1% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | 41.1%promedio 5A ≈40.3% | ≈40.3% | · | · | |
| Revenue CAGR 5Y (Ingresos CAGR 5A) | 42.6% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | NTRA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 1.1promedio 5A ≈0.8 | ≈0.8 | 0.5 | De primer nivel | |
| Receivables Turnover (Rotación de Cuentas por Cobrar) | 7.6promedio 5A ≈5.6 | ≈5.6 | 6.4 | De primer nivel | |
| Revenue / Employee (Ingresos / Empleado) | ≈$375.9K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
17.2%
Próximo informe
Nov 04, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 5, 2026 | $-0.47 | $-0.50 | 6.7% |
| 31 de marzo de 2026 | May 7, 2026 | $-0.60 | $-0.55 | -9.7% |
| 31 de diciembre de 2025 | $0.36 | $-0.52 | 169.1% | |
| 30 de septiembre de 2025 | $-0.64 | $-0.38 | -68.2% | |
| 30 de junio de 2025 | $-0.74 | $-0.63 | -17.8% | |
| 31 de marzo de 2025 | $-0.50 | $-0.65 | 23.1% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.31B | $1.70B | $1.08B | $820M | $625M | $391M | $302M | $258M | $210M | $213M | $190M | $159M | |
| Cost of Revenue | · | · | · | · | · | · | · | $158M | $136M | $134M | $113M | $78M | |
| R&D Expense | $624M | $404M | $321M | $316M | $264M | $100M | $51M | $51M | $50M | $42M | $28M | $17M | |
| SG&A Expense | $1.18B | $841M | $618M | $589M | $511M | $304M | $206M | $155M | $155M | $136M | $110M | $63M | |
| Operating Expenses | $2.62B | $1.92B | $1.53B | $1.36B | $1.09B | $607M | $419M | $372M | $345M | $314M | $250M | $159M | |
| Operating Income | $-310M | $-222M | $-446M | $-541M | $-468M | $-216M | $-116M | $-115M | $-135M | $-101M | $-60M | $665.0K | |
| Interest Expense | $4M | $11M | $13M | $9M | $8M | $15M | $11M | $10M | $4M | $533.0K | $4M | $4M | |
| Other Non-op | · | · | · | · | · | · | · | · | · | · | $-8M | $-2M | |
| Pretax Income | $-268M | $-190M | $-435M | $-547M | $-471M | $-230M | $-123M | $-128M | $-137M | $-100M | $-70M | $-5M | |
| Income Tax | $-60M | $695.0K | $271.0K | $978.0K | $618.0K | $98.0K | $2M | $321.0K | $454.0K | $142.0K | · | $15.0K | |
| Net Income | $-208M | $-190M | $-435M | $-548M | $-472M | $-230M | $-125M | $-128M | $-138M | $-100M | $-70M | $-5M | |
| EPS (Basic) | $-1.52 | $-1.53 | $-3.78 | $-5.57 | $-5.21 | $-2.84 | $-1.79 | $-2.22 | $-2.58 | $-1.95 | $-2.68 | · | |
| EPS (Diluted) | $-1.52 | $-1.53 | $-3.78 | $-5.57 | $-5.21 | $-2.84 | $-1.79 | $-2.22 | $-2.59 | $-1.95 | $-2.68 | · | |
| Shares (Basic) | 136,721,000 | 124,718,000 | 114,997,000 | 98,408,000 | 90,558,000 | 81,011,000 | 69,555,000 | 57,848,000 | 53,312,000 | 51,576,000 | 26,204,000 | · | |
| Shares (Diluted) | 136,721,000 | 124,718,000 | 114,997,000 | 98,408,000 | 90,558,000 | 81,011,000 | 69,555,000 | 57,848,000 | 53,604,000 | 51,576,000 | 26,204,000 | · | |
| EBITDA | $-268M | $-191M | $-422M | $-524M | $-457M | $-208M | $-109M | $-107M | $-127M | $-90M | $-54M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | $466M | $84M | $49M | $62M | $46M | $13M | $15M | $29M | $87M | |
| Short-term Investments | · | $23M | $237M | $432M | $830M | $689M | $379M | $107M | $106M | $131M | $202M | · | |
| Receivables | $297M | $314M | $278M | $244M | $122M | $79M | $53M | $62M | $44M | $13M | $6M | $6M | |
| Inventory | $68M | $45M | $41M | $35M | $27M | $20M | $12M | $14M | $9M | $6M | $8M | $12M | |
| Prepaid Expense | $56M | $49M | $61M | $34M | $30M | $27M | $16M | $6M | $9M | $7M | $5M | $1M | |
| Current Assets | $1.50B | $1.38B | $1.26B | $1.21B | $1.09B | $863M | $523M | $241M | $181M | $174M | $251M | $106M | |
| PP&E (Net) | $241M | $162M | $111M | $92M | $66M | $33M | $23M | $24M | $30M | $32M | $13M | $15M | |
| PP&E (Gross) | $352M | $240M | $168M | $128M | $85M | $83M | $65M | $59M | $57M | $52M | $26M | $24M | |
| Accum. Depreciation | $111M | $78M | $56M | $36M | $19M | $50M | $42M | $34M | $27M | $19M | $14M | $10M | |
| Goodwill | $141M | · | · | · | · | · | · | · | · | · | · | · | |
| Intangibles | $374M | $11M | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $37M | $26M | $15M | $18M | $19M | $15M | $12M | $3M | $4M | $4M | $1M | $2M | |
| Total Assets | $2.40B | $1.66B | $1.44B | $1.39B | $1.24B | $932M | $583M | $268M | $215M | $211M | $265M | $124M | |
| Accounts Payable | $33M | $35M | $15M | $31M | $27M | $8M | $9M | $15M | $9M | $11M | $7M | $9M | |
| Accrued Liabilities | · | · | · | · | · | $60M | $49M | $32M | $33M | $20M | $19M | $10M | |
| Short-term Debt | $80M | $80M | $80M | $80M | $50M | $50M | $50M | $50M | $50M | $50M | $42M | · | |
| Current Liabilities | $441M | $344M | $307M | $310M | $219M | $199M | $180M | $114M | $106M | $96M | $80M | $30M | |
| Capital Leases | $118M | $97M | $67M | $77M | $61M | $21M | $26M | · | · | · | · | · | |
| Other Non-current Liabilities | $12M | $8M | · | · | $1M | $320.0K | $310.0K | · | $1M | · | · | · | |
| Total Liabilities | $686M | $465M | $676M | $689M | $583M | $446M | $304M | $236M | $189M | $104M | $80M | $54M | |
| Long-term Debt | · | · | $283M | $282M | $280M | · | · | · | · | · | · | · | |
| Total Debt | $80M | $80M | $80M | $80M | $50M | $50M | $50M | $50M | $50M | $50M | $42M | · | |
| Common Stock | $14.0K | $12.0K | $11.0K | $11.0K | $10.0K | $9.0K | $8.0K | $7.0K | $6.0K | $5.0K | $5.0K | $1.0K | |
| Retained Earnings | $-2.78B | $-2.57B | $-2.38B | $-1.94B | $-1.39B | $-929M | $-699M | $-575M | $-446M | $-346M | $-250M | $-180M | |
| AOCI | $-258.0K | $-344.0K | $-3M | $-16M | $-2M | $4M | $919.0K | $-552.0K | $-766.0K | $-725.0K | $-1M | · | |
| Stockholders' Equity | $1.71B | $1.20B | $765M | $706M | $653M | $486M | $279M | $32M | $25M | $144M | $226M | $-171M | |
| Liabilities + Equity | $2.40B | $1.66B | $1.44B | $1.39B | $1.24B | $932M | $583M | $268M | $215M | $211M | $265M | $124M | |
| Shares Outstanding | 139,693,000 | 132,646,000 | 119,581,000 | 111,255,000 | 95,140,000 | 86,223,000 | 78,005,000 | 62,083,000 | 54,040,000 | 52,665,000 | 50,346,000 | 6,879,000 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $42M | $31M | $24M | $17M | $11M | $9M | $8M | $8M | $7M | $6M | $6M | $5M | |
| Stock-based Comp | $354M | $274M | $192M | $152M | $115M | $50M | $29M | $14M | $11M | $11M | $7M | $5M | |
| Amort. of Intangibles | $4M | $1M | $0 | · | · | · | $1M | $1M | $1M | $600.0K | $200.0K | $0 | |
| Restructuring | · | · | · | · | $400.0K | $400.0K | · | · | · | · | · | · | |
| Other Non-cash | $27M | $21M | $-28M | $-53M | $10M | $-12M | $25M | $36M | $21M | $5M | $20M | · | |
| Operating Cash Flow | $215M | $136M | $-247M | $-432M | $-335M | $-183M | $-63M | $-71M | $-98M | $-74M | $-38M | $10M | |
| CapEx | $106M | $66M | $39M | $48M | $41M | $20M | $5M | $4M | $10M | $23M | $8M | $10M | |
| Investing Cash Flow | $-132M | $138M | $168M | $330M | $-205M | $-331M | $-266M | $-5M | $14M | $47M | $-211M | · | |
| Debt Issued | · | · | · | · | · | · | · | · | $75M | · | · | · | |
| Net Debt Issued | · | · | · | · | · | · | · | · | $75M | · | · | · | |
| Financing Cash Flow | $47M | $30M | $254M | $483M | $576M | $501M | $341M | $114M | $80M | $13M | $190M | · | |
| Net Change in Cash | · | · | · | · | · | · | · | · | $-3M | $-14M | $-58M | · | |
| Taxes Paid | $499.0K | $1M | $295.0K | $549.0K | $283.0K | $67.0K | $2M | $332.0K | $177.0K | · | · | · | |
| Free Cash Flow | $109M | $69M | $-286M | $-479M | $-376M | $-202M | $-68M | $-74M | $-107M | $-97M | $-46M | · | |
| Levered FCF | $106M | $59M | $-299M | $-489M | $-385M | $-217M | $-79M | $-85M | $-111M | $-98M | · | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -13.4% | -13.1% | -41.2% | -66.0% | -74.9% | -55.3% | -38.5% | -44.5% | -63.5% | -44.5% | -31.4% | · | |
| Net Margin | -9.0% | -11.2% | -40.2% | -66.8% | -75.4% | -58.8% | -41.3% | -49.7% | -64.6% | -44.1% | -36.9% | · | |
| Pretax Margin | -11.6% | -11.2% | -40.1% | -66.7% | -75.3% | -58.7% | -40.6% | -49.6% | -64.4% | -44.0% | · | · | |
| EBITDA Margin | -11.6% | -11.3% | -39.0% | -63.9% | -73.0% | -53.1% | -35.9% | -41.6% | -60.2% | -41.6% | -28.5% | · | |
| ROA | -10.3% | -12.3% | -30.7% | -41.6% | -43.5% | -30.3% | -29.3% | -53.1% | -70.0% | -40.2% | -36.1% | · | |
| ROE | -14.1% | -18.4% | -56.1% | -102.6% | -66.8% | -45.0% | -68.7% | -288.9% | -204.7% | -57.5% | -1046.5% | · | |
| ROIC | -13.4% | -17.5% | -52.8% | -69.0% | -66.6% | -40.4% | -35.9% | -139.6% | -338.4% | -61.9% | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | 4.0 | 4.1 | 3.9 | 5.0 | 4.3 | 2.9 | 2.1 | 1.4 | 1.8 | 3.1 | · | |
| Quick Ratio | 0.7 | 1.0 | 1.7 | 3.7 | 4.7 | 4.1 | 2.7 | 1.9 | 1.2 | 1.7 | 2.9 | · | |
| Debt / Equity | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 1.6 | -4.8 | 0.5 | 0.2 | · | |
| Interest Coverage | -76.2 | -20.8 | -35.3 | -58.1 | -56.4 | -14.3 | -10.9 | -10.9 | -31.8 | -181.0 | -17.1 | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.1 | 1.1 | 0.8 | 0.6 | 0.6 | 0.5 | 0.7 | 1.1 | 1.1 | 0.9 | 1.0 | · | |
| Inventory Turnover | · | · | · | · | · | · | · | 14.0 | 17.6 | 18.7 | 11.5 | · | |
| Receivables Turnover | 7.6 | 5.7 | 4.1 | 4.5 | 6.2 | 5.9 | 5.2 | 4.8 | 19.5 | 22.5 | 32.3 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $12.26 | $9.01 | $6.40 | $6.34 | $6.87 | $5.64 | $3.57 | $0.52 | $-0.19 | $2.02 | $3.67 | · | |
| Revenue / Share | $16.87 | $13.61 | $9.41 | $8.33 | $6.91 | · | $4.35 | $4.45 | $3.94 | · | · | · | |
| Cash Flow / Share | $1.57 | $1.09 | $-2.15 | $-4.38 | $-3.70 | · | $-0.91 | $-1.22 | $-1.81 | · | · | · | |
| Cash / Share | · | · | · | $4.19 | $0.89 | $0.56 | $0.79 | $0.75 | $0.23 | $0.29 | $0.57 | · | |
| EPS (TTM) | $-1.52 | $-1.53 | $-3.78 | $-5.57 | $-5.21 | $-2.84 | $-1.79 | $-2.22 | $-2.59 | $-1.95 | $-2.68 | · |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 35.9% | 56.8% | 32.0% | 31.1% | 60.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 41.1% | 39.5% | 40.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 42.6% | · | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.31B | $1.70B | $1.08B | $820M | $625M | $391M | $302M | $258M | $210M | $213M | $190M | · | |
| Net Income TTM | $-208M | $-190M | $-435M | $-548M | $-472M | $-230M | $-125M | $-128M | $-138M | $-100M | $-70M | · | |
| Market Cap | $32.00B | $21.00B | $7.49B | $4.47B | $8.89B | $8.58B | $2.63B | $867M | $486M | $617M | $544M | · | |
| Enterprise Value | · | · | · | $3.65B | $8.02B | $7.89B | $2.24B | $763M | $417M | $520M | $355M | · | |
| P/E | -150.7 | -103.5 | -16.6 | -7.2 | -17.9 | -35.0 | -18.8 | -6.3 | -3.5 | -6.0 | -4.0 | · | |
| P/S | 13.9 | 12.4 | 6.9 | 5.4 | 14.2 | 21.9 | 8.7 | 3.4 | 2.3 | 2.9 | 2.9 | · | |
| P/B | 18.7 | 17.6 | 9.8 | 6.3 | 13.6 | 17.6 | 9.4 | 26.9 | -46.8 | 5.8 | 2.9 | · | |
| P / Tangible Book | 26.7 | 17.7 | 9.8 | 6.3 | 13.6 | 17.6 | · | · | · | · | · | · | |
| P / Cash Flow | 148.6 | 154.8 | -30.3 | -10.4 | -26.5 | -47.0 | -41.4 | -12.3 | -5.0 | -8.3 | -14.4 | · | |
| P / FCF | 293.3 | 303.3 | -26.2 | -9.3 | -23.6 | -42.5 | -38.4 | -11.6 | -4.6 | -6.4 | -11.9 | · | |
| EV / EBITDA | · | · | · | -7.0 | -17.6 | -38.0 | -20.6 | -7.1 | -3.3 | -5.8 | -6.5 | · | |
| EV / FCF | · | · | · | -7.6 | -21.3 | -39.1 | -32.7 | -10.2 | -3.9 | -5.4 | -7.8 | · | |
| EV / Revenue | · | · | · | 4.5 | 12.8 | 20.2 | 7.4 | 3.0 | 2.0 | 2.4 | 1.9 | · | |
| Earnings Yield | -0.66% | -0.97% | -6.0% | -13.9% | -5.6% | -2.9% | -5.3% | -15.9% | -28.8% | -16.7% | -24.8% | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $753M | $697M | $666M | $592M | $547M | $502M | $476M | $440M | $413M | $368M | $311M | $268M | $261M | $242M | $217M | $211M | |
| R&D Expense | $228M | $211M | $175M | $173M | $146M | $129M | $129M | $97M | $89M | $89M | $83M | $77M | $78M | $82M | $88M | $66M | |
| SG&A Expense | $327M | $328M | $291M | $309M | $311M | $267M | $235M | $214M | $198M | $194M | $161M | $155M | $153M | $150M | $144M | $148M | |
| Operating Expenses | $829M | $790M | $688M | $690M | $657M | $581M | $541M | $479M | $457M | $442M | $396M | $379M | $374M | $380M | $359M | $330M | |
| Operating Income | $-76M | $-94M | $-23M | $-98M | $-110M | $-79M | $-65M | $-39M | $-44M | $-74M | $-85M | $-111M | $-112M | $-138M | $-142M | $-119M | |
| Interest Expense | · | · | $990.0K | $1M | $1M | $1M | $1M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | |
| Other Non-op | $9M | $10M | · | · | $11M | $13M | · | · | · | · | · | · | · | · | · | · | |
| Pretax Income | $-67M | $-85M | $-13M | $-87M | $-101M | $-67M | $-55M | $-31M | $-37M | $-67M | $-78M | $-109M | $-111M | $-137M | $-142M | $-121M | |
| Income Tax | $-261.0K | $283.0K | $-61M | $207.0K | $275.0K | $173.0K | $-1M | $730.0K | $892.0K | $428.0K | $191.0K | $202.0K | $-282.0K | $160.0K | $421.0K | $185.0K | |
| Net Income | $-67M | $-85M | $47M | $-88M | $-101M | $-67M | $-54M | $-32M | $-37M | $-68M | $-78M | $-109M | $-111M | $-137M | $-143M | $-121M | |
| EPS (Basic) | $-0.47 | $-0.60 | $0.36 | $-0.64 | $-0.74 | $-0.50 | $-0.41 | $-0.26 | $-0.30 | $-0.56 | $-0.63 | $-0.95 | $-0.97 | $-1.23 | $-1.37 | $-1.25 | |
| EPS (Diluted) | $-0.47 | $-0.60 | $0.36 | $-0.64 | $-0.74 | $-0.50 | $-0.41 | $-0.26 | $-0.30 | $-0.56 | $-0.63 | $-0.95 | $-0.97 | $-1.23 | $-1.37 | $-1.25 | |
| Shares (Basic) | 143,279,000 | 141,502,000 | · | 137,187,000 | 136,388,000 | 134,750,000 | · | 123,775,000 | 122,853,000 | 120,814,000 | · | 115,171,000 | 113,690,000 | 111,767,000 | · | 97,052,000 | |
| Shares (Diluted) | 143,279,000 | 141,502,000 | · | 137,187,000 | 136,388,000 | 134,750,000 | · | 123,775,000 | 122,853,000 | 120,814,000 | · | 115,171,000 | 113,690,000 | 111,767,000 | · | 97,052,000 | |
| EBITDA | $-76M | $-79M | · | $-98M | $-110M | $-70M | · | $-39M | $-44M | $-67M | · | $-111M | $-112M | $-133M | · | $-119M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $57M | |
| Short-term Investments | · | · | · | $1M | $16M | $18M | $23M | $29M | $90M | $69M | · | $268M | $355M | $409M | · | $464M | |
| Receivables | $422M | $418M | $297M | $286M | $309M | $318M | $314M | $307M | $336M | $289M | · | $255M | $260M | $247M | · | $236M | |
| Inventory | $80M | $71M | $68M | $65M | $54M | $50M | $45M | $49M | $41M | $43M | · | $42M | $43M | $41M | · | $40M | |
| Prepaid Expense | $65M | $76M | $56M | $54M | $52M | $56M | $49M | $45M | $38M | $47M | · | $33M | $27M | $30M | · | $32M | |
| Current Assets | $1.66B | $1.65B | $1.50B | $1.45B | $1.43B | $1.42B | $1.38B | $1.32B | $1.30B | $1.26B | · | $1.27B | $1.07B | $1.13B | · | $830M | |
| PP&E (Net) | $318M | $269M | $241M | $206M | $189M | $180M | $162M | $142M | $133M | $126M | · | $105M | $103M | $101M | · | $87M | |
| PP&E (Gross) | $451M | $390M | $352M | $307M | $281M | $267M | $240M | $213M | $198M | $185M | · | $155M | $148M | $141M | · | $119M | |
| Accum. Depreciation | $133M | $120M | $111M | $101M | $92M | $87M | $78M | $71M | $64M | $59M | · | $51M | $45M | $41M | · | $31M | |
| Goodwill | $141M | $141M | $141M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Intangibles | $360M | $367M | $374M | · | · | · | $11M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $50M | $51M | $37M | $71M | $41M | $41M | $26M | $38M | $29M | $26M | · | $16M | $18M | $19M | · | $18M | |
| Total Assets | $2.66B | $2.61B | $2.40B | $1.82B | $1.76B | $1.73B | $1.66B | $1.59B | $1.52B | $1.47B | · | $1.45B | $1.25B | $1.32B | · | $1.01B | |
| Accounts Payable | $75M | $62M | $33M | $46M | $37M | $39M | $35M | $28M | $33M | $26M | · | $21M | $21M | $36M | · | $34M | |
| Short-term Debt | $80M | $80M | $80M | $80M | $80M | $80M | $80M | $80M | $80M | $80M | · | $80M | $80M | $80M | · | $50M | |
| Current Liabilities | $553M | $558M | $441M | $442M | $385M | $366M | $344M | $301M | $315M | $306M | · | $290M | $277M | $291M | · | $267M | |
| Capital Leases | $143M | $145M | $118M | $104M | $103M | $103M | $97M | $99M | $61M | $64M | · | $68M | $71M | $74M | · | $78M | |
| Other Non-current Liabilities | $25M | $16M | $12M | · | · | · | $8M | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $836M | $840M | $686M | $569M | $511M | $493M | $465M | $712M | $680M | $674M | · | $662M | $652M | $668M | · | $647M | |
| Total Debt | $80M | $80M | · | $80M | $80M | $80M | · | $80M | $80M | $80M | · | $80M | $80M | $80M | · | $50M | |
| Common Stock | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $12.0K | $12.0K | $12.0K | $12.0K | · | $11.0K | $11.0K | $11.0K | · | $10.0K | |
| Retained Earnings | $-2.93B | $-2.86B | $-2.78B | $-2.82B | $-2.74B | $-2.63B | $-2.57B | $-2.51B | $-2.48B | $-2.45B | · | $-2.30B | $-2.19B | $-2.08B | · | $-1.80B | |
| AOCI | $-108.0K | $-202.0K | $-258.0K | $-187.0K | $-287.0K | $-197.0K | $-344.0K | $-765.0K | $-1M | $-2M | $-3M | $-5M | $-9M | $-12M | $-16M | $-20M | |
| Stockholders' Equity | $1.82B | $1.77B | $1.71B | $1.25B | $1.25B | $1.24B | $1.20B | $879M | $837M | $794M | $765M | $785M | $596M | $651M | $706M | $362M | |
| Liabilities + Equity | $2.66B | $2.61B | $2.40B | $1.82B | $1.76B | $1.73B | $1.66B | $1.59B | $1.52B | $1.47B | · | $1.45B | $1.25B | $1.32B | · | $1.01B | |
| Shares Outstanding | 143,612,000 | 142,734,000 | 139,693,000 | 137,533,000 | 136,757,000 | 135,932,000 | 132,646,000 | 124,137,000 | 123,365,000 | 122,234,000 | · | 118,990,000 | 114,051,000 | 113,359,000 | · | 97,300,000 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $15M | $15M | $12M | $10M | $10M | $9M | $8M | $8M | $8M | $7M | $7M | $7M | $5M | $5M | $4M | $5M | |
| Stock-based Comp | $103M | $95M | $93M | $91M | $93M | $78M | $72M | $71M | $67M | $64M | $49M | $57M | $44M | $40M | $36M | $40M | |
| Amort. of Intangibles | $6M | $7M | · | · | $0 | $300.0K | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $16M | · | · | · | $24M | · | · | · | $23M | · | · | · | $10M | · | · | |
| Operating Cash Flow | $55M | $40M | $74M | $59M | $38M | $44M | $53M | $52M | $4M | $27M | $-58M | $-30M | $-79M | $-81M | $-81M | $-102M | |
| CapEx | $63M | $22M | $36M | $22M | $26M | $22M | $18M | $16M | $12M | $20M | $10M | $9M | $9M | $11M | $12M | $12M | |
| Investing Cash Flow | $-63M | $-32M | $-72M | $-20M | $-24M | $-17M | $-11M | $43M | $-32M | $138M | $24M | $82M | $47M | $16M | $22M | $67M | |
| Financing Cash Flow | $12M | $4M | $32M | $2M | $13M | $544.0K | $11M | $2M | $11M | $6M | $7M | $236M | $9M | $2M | $468M | $1M | |
| Net Change in Cash | $4M | $12M | · | · | $26M | $28M | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $18M | · | · | · | $23M | · | · | · | $7M | · | · | · | $-92M | · | · | |
| Levered FCF | · | · | · | · | · | $22M | · | · | · | $4M | · | · | · | $-96M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -10.1% | -13.4% | · | -16.5% | -20.2% | -15.8% | · | -8.9% | -10.6% | -20.2% | · | -41.4% | -43.0% | -57.2% | · | -56.5% | |
| Net Margin | -8.9% | -12.2% | · | -14.8% | -18.5% | -13.3% | · | -7.2% | -9.1% | -18.4% | · | -40.6% | -42.4% | -56.6% | · | -57.7% | |
| Pretax Margin | -8.9% | -12.2% | · | -14.8% | -18.4% | -13.3% | · | -7.0% | -8.8% | -18.3% | · | -40.6% | -42.5% | -56.6% | · | -57.6% | |
| EBITDA Margin | -10.1% | -11.3% | · | -16.5% | -20.2% | -13.9% | · | -8.9% | -10.6% | -18.3% | · | -41.4% | -43.0% | -55.1% | · | -56.5% | |
| ROA | -3.0% | -3.9% | · | -5.1% | -6.2% | -4.2% | · | -2.1% | -2.7% | -4.9% | · | -8.9% | -9.6% | -11.1% | · | -10.5% | |
| ROE | -4.4% | -5.7% | · | -8.2% | -9.7% | -6.6% | · | -3.8% | -5.2% | -9.4% | · | -19.0% | -21.3% | -23.0% | · | -21.7% | |
| ROIC | -4.0% | -5.1% | · | -7.3% | -8.3% | -6.0% | · | -4.2% | -4.9% | -8.6% | · | -12.8% | -16.6% | -18.9% | · | -29.0% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.0 | 3.0 | · | 3.3 | 3.7 | 3.9 | · | 4.4 | 4.1 | 4.1 | · | 4.4 | 3.8 | 3.9 | · | 3.1 | |
| Quick Ratio | 0.8 | 0.7 | · | 0.7 | 0.8 | 0.9 | · | 1.1 | 1.4 | 1.2 | · | 1.8 | 2.2 | 2.3 | · | 2.8 | |
| Debt / Equity | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Interest Coverage | · | · | · | -93.4 | -107.3 | -78.8 | · | -12.5 | -14.0 | -23.8 | · | -34.1 | -35.4 | -45.2 | · | -51.1 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 2.1 | 1.9 | · | 2.0 | 1.7 | 1.7 | · | 1.6 | 1.4 | 1.4 | · | 1.1 | 1.1 | 1.2 | · | 1.2 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $12.68 | $12.43 | · | $9.10 | $9.11 | $9.12 | · | $7.08 | $6.78 | $6.50 | · | $6.59 | $5.23 | $5.74 | · | $3.72 | |
| Revenue / Share | $5.25 | $4.92 | · | $4.32 | $4.01 | $3.72 | · | $3.55 | $3.36 | $3.04 | · | $2.33 | $2.30 | $2.16 | · | $2.17 | |
| Cash Flow / Share | · | $0.28 | · | · | · | $0.33 | · | · | · | $0.22 | · | · | · | $-0.72 | · | · | |
| Cash / Share | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0.59 | |
| EPS (TTM) | $-1.35 | $-1.62 | · | $-2.29 | $-1.91 | $-1.47 | · | $-1.75 | $-2.44 | $-3.11 | · | $-4.52 | $-4.82 | $-5.35 | · | $-5.72 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.71B | $2.50B | · | $2.12B | $1.96B | $1.83B | · | $1.53B | $1.36B | $1.21B | · | $989M | $931M | $868M | · | $776M | |
| Net Income TTM | $-192M | $-226M | · | $-309M | $-253M | $-190M | · | $-215M | $-292M | $-365M | · | $-499M | $-512M | $-546M | · | $-546M | |
| Market Cap | $38.98B | $28.55B | · | $22.14B | $23.10B | $19.22B | · | $15.76B | $13.36B | $11.18B | · | $5.27B | $5.55B | $6.29B | · | $4.26B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $3.79B | |
| P/E | -201.1 | -123.5 | · | -70.3 | -88.5 | -96.2 | · | -72.5 | -44.4 | -29.4 | · | -9.8 | -10.1 | -10.4 | · | -7.7 | |
| P/S | 14.4 | 11.4 | · | 10.5 | 11.8 | 10.5 | · | 10.3 | 9.8 | 9.3 | · | 5.3 | 6.0 | 7.3 | · | 5.5 | |
| P/B | 21.4 | 16.1 | · | 17.7 | 18.5 | 15.5 | · | 17.9 | 16.0 | 14.1 | · | 6.7 | 9.3 | 9.7 | · | 11.8 | |
| P / Tangible Book | 29.5 | 22.6 | · | 17.7 | 18.5 | 15.5 | · | 17.9 | 16.0 | 14.1 | · | 6.7 | 9.3 | 9.7 | · | 11.8 | |
| P / Cash Flow | · | 710.6 | · | · | · | 432.4 | · | · | · | 414.0 | · | · | · | -77.8 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 4.9 | |
| Earnings Yield | -0.50% | -0.81% | · | -1.4% | -1.1% | -1.0% | · | -1.4% | -2.2% | -3.4% | · | -10.2% | -9.9% | -9.6% | · | -13.1% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $2.31B | $1.70B | $1.08B | $820M | $625M |
| Margen Operativo % | -13.4% | -13.1% | -41.2% | -66.0% | -74.9% |
| Beneficio neto | $-208M | $-190M | $-435M | $-548M | $-472M |
| EPS Diluido | $-1.52 | $-1.53 | $-3.78 | $-5.57 | $-5.21 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Deuda / Patrimonio | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 |
| Ratio corriente | 3.4 | 4.0 | 4.1 | 3.9 | 5.0 |
| Ratio Rápido | 0.7 | 1.0 | 1.7 | 3.7 | 4.7 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $109M | $69M | $-286M | $-479M | $-376M |
Propietarios institucionales (13F) 928 declarantes · $36.5B total · A fecha de 30 de septiembre de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
928
Valor en tenencia
$36.5B
Nuevas posiciones
166
Posiciones cerradas
63
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 166 (+55 vs trimestre anterior) | 63 (-37 vs trimestre anterior) | 359 (+56 vs trimestre anterior) | 247 (-14 vs trimestre anterior) | +8.7M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| JPMORGAN CHASE & CO | $3 505 094 525 | 12 865 346 | 9,61% | Acciones |
| BlackRock, Inc. | $2 962 770 331 | 10 914 608 | 8,12% | Acciones |
| VANGUARD GROUP INC | $2 819 278 675 | 12 306 424 | 7,73% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $1 690 649 234 | 6 228 216 | 4,63% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 569 697 628 | 5 782 640 | 4,30% | Acciones |
| FMR LLC | $1 479 781 281 | 5 451 396 | 4,06% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $1 096 858 330 | 4 040 738 | 3,01% | Acciones |
| STATE STREET CORP | $992 317 506 | 3 655 618 | 2,72% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $744 565 293 | 2 750 013 | 2,04% | Acciones |
| FRANKLIN RESOURCES INC | $739 946 472 | 2 725 903 | 2,03% | Acciones |
| Castle Hook Partners LP | $704 759 120 | 2 596 276 | 1,93% | Acciones |
| COATUE MANAGEMENT LLC | $680 006 681 | 2 505 090 | 1,86% | Acciones |
| AQR CAPITAL MANAGEMENT LLC | $628 086 698 | 2 344 570 | 1,72% | Acciones |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $602 175 451 | 2 218 366 | 1,65% | Acciones |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $535 084 922 | 1 971 391 | 1,47% | Acciones |
| NORGES BANK | $496 243 717 | 1 828 122 | 1,36% | Acciones |
| FRED ALGER MANAGEMENT, LLC | $482 640 543 | 1 778 009 | 1,32% | Acciones |
| GOLDMAN SACHS GROUP INC | $466 935 338 | 1 720 152 | 1,28% | Acciones |
| Sofinnova Investments, Inc. | $420 823 506 | 1 550 280 | 1,15% | Acciones |
| Capital World Investors | $408 365 851 | 1 504 387 | 1,12% | Acciones |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $408 180 994 | 1 503 706 | 1,12% | Acciones |
| MAVERICK CAPITAL LTD | $368 266 171 | 1 356 663 | 1,01% | Acciones |
| D. E. Shaw & Co., Inc. | $347 253 770 | 1 279 255 | 0,95% | Acciones |
| MORGAN STANLEY | $345 906 057 | 1 274 287 | 0,95% | Acciones |
| FEDERATED HERMES, INC. | $309 172 863 | 1 138 968 | 0,85% | Acciones |
| Clearbridge Investments, LLC | $276 424 438 | 1 018 325 | 0,76% | Acciones |
| RTW INVESTMENTS, LP | $271 450 000 | 1 000 000 | 0,74% | Acciones |
| JANE STREET GROUP, LLC | $251 630 350 | 926 986 | 0,69% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $249 356 413 | 918 609 | 0,68% | Acciones |
| Invesco Ltd. | $237 065 949 | 873 332 | 0,65% | Acciones |
| NORTHERN TRUST CORP | $227 070 096 | 836 508 | 0,62% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $218 934 197 | 806 536 | 0,60% | Acciones |
| BANK OF AMERICA CORP /DE/ | $199 960 146 | 736 637 | 0,55% | Acciones |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $197 243 187 | 726 628 | 0,54% | Acciones |
| ARK Investment Management LLC | $186 989 592 | 688 855 | 0,51% | Acciones |
| Sumitomo Mitsui Trust Group, Inc. | $174 716 892 | 643 643 | 0,48% | Acciones |
| Chevy Chase Trust Holdings, LLC | $162 830 912 | 599 856 | 0,45% | Acciones |
| RAYMOND JAMES FINANCIAL INC | $160 992 382 | 593 083 | 0,44% | Acciones |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $160 551 817 | 591 460 | 0,44% | Acciones |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $150 579 670 | 752 936 | 0,41% | Acciones |
| UBS Group AG | $150 312 452 | 553 739 | 0,41% | Acciones |
| Legal & General Group Plc | $150 142 799 | 553 114 | 0,41% | Acciones |
| Bank of New York Mellon Corp | $149 277 609 | 549 927 | 0,41% | Acciones |
| FIRST TRUST ADVISORS LP | $138 768 953 | 511 214 | 0,38% | Acciones |
| WELLS FARGO & COMPANY/MN | $136 489 991 | 502 818 | 0,37% | Acciones |
| Nuveen, LLC | $135 477 536 | 499 089 | 0,37% | Acciones |
| GILDER GAGNON HOWE & CO LLC | $135 199 396 | 498 064 | 0,37% | Acciones |
| AMERICAN CENTURY COMPANIES INC | $129 951 802 | 478 732 | 0,36% | Acciones |
| VICTORY CAPITAL MANAGEMENT INC | $125 949 543 | 463 988 | 0,35% | Acciones |
| Avala Global LP | $124 867 000 | 460 000 | 0,34% | Acciones |
Activistas y propietarios del %+ 5 1 tenencia
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Sofinnova Venture Partners VIII, L.P. (“SVP VIII”), Sofinnova Management VIII, L.L.C., Sofinnova Venture Partners IX, L.P. (“SVP IX”), Sofinnova Management IX, L.L.C., Dr. Michael F. Powell (“Powell”), Dr. James I. Healy ×3 presentaciones | 13 de febrero de 2020 | · | Presentación inicial | Inversión pasiva | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 21 insiders · 7 directivos · 15 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Steven Leonard Chapman | CEO AND PRESIDENT | 1 de octubre de 2026 S | 96 926 | 0 | 54 | $-90 749 334 |
| Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 4 de agosto de 2026 S | 51 637 | 0 | 41 | $-21 731 496 |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 1 de octubre de 2026 S | 106 914 | 0 | 64 | $-23 640 470 |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | 10 de agosto de 2026 S | 197 257 | 0 | 18 | $-9 345 666 |
| Robert Alan Schueren | CHIEF OPERATING OFFICER | 27 de enero de 2023 A | 24 091 | 0 | 0 | $0 |
| Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 15 de septiembre de 2026 S | 0 | 0 | 92 | $-124 045 289 |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 3 de agosto de 2026 S | 170 073 | 0 | 41 | $-23 609 158 |
| Jonathan Sheena | Consejero | 23 de septiembre de 2026 S | 9 000 | 0 | 144 | $-29 839 868 |
| Rowan E Chapman | Consejero | 15 de julio de 2026 S | 4 663 | 0 | 5 | $-1 764 386 |
| Eric H Rubin | Consejero | 26 de junio de 2026 A | 2 204 | 0 | 0 | $0 |
| Monica Bertagnolli | Consejero | 26 de junio de 2026 A | 7 020 | 0 | 0 | $0 |
| Gail Boxer Marcus | Consejero | 26 de junio de 2026 A | 7 852 | 0 | 5 | $-2 413 550 |
| Roy D. Baynes | Consejero | 26 de junio de 2026 A | 20 158 | 0 | 8 | $-2 809 687 |
| Thomas J. Lynch Jr. | Consejero | 26 de junio de 2026 A | 1 905 | 0 | 0 | $0 |
| Herm Rosenman | Consejero | 26 de junio de 2026 A | 5 927 | 0 | 5 | $-15 143 996 |
| ROELOF BOTHA ("RB") | Consejero | 26 de junio de 2026 A | 4 585 | 0 | 17 | $-34 892 929 |
| Dr. James I. Healy | Consejero | 25 de abril de 2025 A | 46 260 | 0 | 0 | $0 |
| Todd C Cozzens | Consejero | 25 de mayo de 2022 M | 15 813 | 0 | 0 | $0 |
| John Steuart | Consejero | 16 de mayo de 2019 M | 7 278 | 0 | 0 | $0 |
| Edward C. Driscoll Jr. | Consejero | 16 de mayo de 2019 M | 52 009 | 0 | 0 | $0 |
| Ruth Williams Brinkley | · | 24 de abril de 2026 A | 5 475 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 75 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| PBE · Invesco Exchange-Traded Fund Trust | 6,31% | 64 039 SH | 5 de octubre de 2026 | Diario |
| ARKG · ARK ETF Trust | 4,13% | 240 145 NS | 31 de julio de 2026 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 3,78% | 26 848 SH | 5 de octubre de 2026 | Diario |
| IBB · iShares Trust | 3,30% | 1 043 662 SH | 11 de septiembre de 2026 | Diario |
| QQQJ · Invesco Exchange-Traded Fund Trust … | 2,94% | 85 185 SH | 5 de octubre de 2026 | Diario |
| MEDI · Harbor ETF Trust | 2,26% | 3 475 NS | 31 de julio de 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 2,23% | 87 424 NS | 31 de julio de 2026 | N-PORT |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 2,23% | 5 764 NS | 31 de julio de 2026 | N-PORT |
| HFGO · Hartford Funds Exchange-Traded Trust | 1,74% | 13 080 NS | 31 de julio de 2026 | N-PORT |
| PDP · Invesco Exchange-Traded Fund Trust | 1,58% | 57 676 SH | 5 de octubre de 2026 | Diario |
| GURU · Global X Funds | 1,52% | 3 466 NS | 31 de julio de 2026 | N-PORT |
| IWP · iShares Trust | 1,31% | 769 818 SH | 11 de septiembre de 2026 | Diario |
| ARKK · ARK ETF Trust | 1,24% | 257 162 NS | 31 de julio de 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 1,01% | 1 802 288 SH | 19 de agosto de 2026 | Diario |
| HQGO · Lattice Strategies Trust | 0,86% | 1 588 NS | 31 de julio de 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,84% | 15 588 NS | 31 de julio de 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 0,80% | 460 NS | 31 de julio de 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,79% | 59 919 NS | 31 de julio de 2026 | N-PORT |
| FTC · First Trust Exchange-Traded AlphaDE… | 0,77% | 37 874 NS | 31 de julio de 2026 | N-PORT |
| TEXN · iShares Trust | 0,74% | 426 SH | 11 de septiembre de 2026 | Diario |
| IYH · iShares Trust | 0,72% | 79 898 SH | 11 de septiembre de 2026 | Diario |
| IMCG · iShares Trust | 0,62% | 75 541 SH | 11 de septiembre de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,54% | 404 713 SH | 19 de agosto de 2026 | Diario |
| FHLC · FIDELITY COVINGTON TRUST | 0,52% | 64 051 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,44% | 1 643 356 SH | 19 de agosto de 2026 | Diario |
| VB · VANGUARD INDEX FUNDS | 0,44% | 3 120 454 SH | 19 de agosto de 2026 | Diario |
| LQAI · Exchange Listed Funds Trust | 0,41% | 34 NS | 31 de julio de 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,38% | 8 233 NS | 31 de julio de 2026 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,36% | 20 763 NS | 31 de julio de 2026 | N-PORT |
| ROUS · Lattice Strategies Trust | 0,35% | 9 234 NS | 31 de julio de 2026 | N-PORT |
| IWR · iShares Trust | 0,33% | 559 634 SH | 11 de septiembre de 2026 | Diario |
| SIZE · iShares Trust | 0,32% | 4 182 SH | 11 de septiembre de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,31% | 20 344 SH | 5 de octubre de 2026 | Diario |
| IMCB · iShares Trust | 0,31% | 15 983 SH | 11 de septiembre de 2026 | Diario |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0,30% | 27 638 NS | 31 de julio de 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,24% | 213 NS | 31 de julio de 2026 | N-PORT |
| EUSA · iShares, Inc. | 0,20% | 12 005 SH | 11 de septiembre de 2026 | Diario |
| ILCG · iShares Trust | 0,14% | 13 232 SH | 11 de septiembre de 2026 | Diario |
| IWF · iShares Trust | 0,14% | 513 245 SH | 11 de septiembre de 2026 | Diario |
| VEGN · ETF Series Solutions | 0,12% | 801 NS | 31 de julio de 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,12% | 2 318 SH | 5 de octubre de 2026 | Diario |
| HEQQ · J.P. Morgan Exchange-Traded Fund Tr… | 0,12% | 132 NS | 31 de julio de 2026 | N-PORT |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0,11% | 216 186 SH | 19 de agosto de 2026 | Diario |
| VFMO · VANGUARD WELLINGTON FUND | 0,10% | 7 532 SH | 19 de agosto de 2026 | Diario |
| HAPI · Harbor ETF Trust | 0,10% | 1 778 NS | 31 de julio de 2026 | N-PORT |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,08% | 21 898 SH | 5 de octubre de 2026 | Diario |
| USCL · iShares Trust | 0,08% | 7 220 SH | 11 de septiembre de 2026 | Diario |
| GARP · iShares Trust | 0,07% | 7 023 SH | 11 de septiembre de 2026 | Diario |
| ILCB · iShares Trust | 0,07% | 2 633 SH | 11 de septiembre de 2026 | Diario |
| IYY · iShares Trust | 0,07% | 6 130 SH | 11 de septiembre de 2026 | Diario |
| ITOT · iShares Trust | 0,06% | 187 328 SH | 11 de septiembre de 2026 | Diario |
| IWB · iShares Trust | 0,06% | 95 076 SH | 11 de septiembre de 2026 | Diario |
| IWV · iShares Trust | 0,06% | 37 512 SH | 11 de septiembre de 2026 | Diario |
| ESGV · VANGUARD WORLD FUND | 0,06% | 30 869 SH | 19 de agosto de 2026 | Diario |
| BKLC · BNY Mellon ETF Trust | 0,06% | 11 523 NS | 31 de julio de 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0,06% | 2 309 NS | 31 de julio de 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,05% | 42 084 NS | 31 de julio de 2026 | N-PORT |
| RECS · Columbia ETF Trust I | 0,05% | 11 689 NS | 31 de julio de 2026 | N-PORT |
| TOK · iShares Trust | 0,05% | 379 SH | 11 de septiembre de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,05% | 4 321 128 SH | 19 de agosto de 2026 | Diario |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,05% | 22 505 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,05% | 11 503 SH | 19 de agosto de 2026 | Diario |
| TOV · EA Series Trust | 0,05% | 479 NS | 31 de julio de 2026 | N-PORT |
| URTH · iShares, Inc. | 0,05% | 11 995 SH | 11 de septiembre de 2026 | Diario |
| CRBN · iShares Trust | 0,05% | 1 666 SH | 11 de septiembre de 2026 | Diario |
| ACWI · iShares Trust | 0,04% | 42 227 SH | 11 de septiembre de 2026 | Diario |
| TILT · FlexShares Trust | 0,04% | 3 402 NS | 31 de julio de 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,04% | 3 537 NS | 31 de julio de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,04% | 18 510 NS | 31 de julio de 2026 | N-PORT |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,03% | 113 866 SH | 19 de agosto de 2026 | Diario |
| DCOR · Dimensional ETF Trust | 0,03% | 3 396 NS | 31 de julio de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,02% | 42 957 NS | 31 de julio de 2026 | N-PORT |
| HDUS · Lattice Strategies Trust | 0,02% | 132 NS | 31 de julio de 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,01% | 1 514 SH | 2 de octubre de 2026 | Diario |
| SMLF · iShares Trust | · | 96 755 SH | 11 de septiembre de 2026 | Diario |
NTRA Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 30 analistas
COMPRA
Objetivo mediano
$360.00
-10,1%
12 40,0%
Compra fuerte
14 46,7%
Compra
4 13,3%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
22 analistas · 2026-10-05Objetivo medio $361.16 -9,9%
Ahora
Precio Actual $400.65
Mín$280.00
Media$361.16
Máx$475.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| NTRA | $32.00B | -150.7 | 35.9% | -9.0% | -14.1% | · |
| AMGN | $176.35B | 23.0 | 10.0% | 21.0% | 95.9% | · |
| GILD | $152.32B | 18.1 | 2.4% | 28.9% | 40.5% | · |
| VRTX | $115.15B | 29.6 | 8.9% | 32.9% | 22.1% | · |
| MRNA | $11.62B | -4.1 | -39.9% | -145.2% | -31.3% | · |
| REGN | $106.21B | 18.6 | 0.99% | 31.4% | 14.7% | · |
| RVMD | · | · | · | · | · | · |
| BIIB | $25.84B | 20.0 | 2.2% | 13.1% | 7.2% | · |
| ALNY | $52.64B | 170.7 | 65.2% | 8.5% | 60.4% | · |
| UTHR | $21.27B | 17.5 | 10.6% | 41.9% | 18.7% | 87.9% |
Últimas noticias Noticias recientes que mencionan a esta empresa
Natera Inc. (NTRA): La selección de acciones del multimillonario Tom Steyer con gran potencial alcista
Yahoo Finance · 5 meses atrás
Stanley Druckenmiller Realizó 1 Gran Apuesta Que Todavía Parece Atractiva Hoy y Redujo 2 Posiciones Principales
Yahoo Finance · 5 meses, 3 semanas atrás
Natera Inc. (NTRA): El potencial alcista atrae al multimillonario Stan Druckenmiller
Yahoo Finance · 5 meses, 3 semanas atrás
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 7, 2026